Programs

HomePrograms ▶ Unrestricted Grants
Unrestricted Grants

Important Notes

Applicants are strongly advised to read the instructions and eligibility criteria before starting an application.
Letters of Intent (LOI) are available on the Foundant Technologies Website.
You must be invited to submit a full application.

 

Anticipated Timeline

July 20, 2021 Letter of Intent Period Opens
September 14, 2021 Deadline for Letter of Intent due by 11:59 pm Eastern Time
December 1, 2021 Invitation from Scientific Grant Review Committee for Full Applications
January 11, 2022 Full Application Deadline due by 11:59 pm Eastern Time
March 2022 Grantee Notification
April/May 2022 Grant Start Date

ats-logo.jpg

ATS Unrestricted Research Grants

5 grants available
$40,000 for 1 year

Target audience:
Early-stage investigators interested in basic science, translational, or clinical research in pulmonary, critical care, and sleep medicine

The focus of these unrestricted research grants is to support early-stage investigators interested in research that advances the knowledge and understanding of pulmonary, critical care, and sleep medicine. A primary goal of the ATS Research Program is to enable early-stage investigators the chance to make the transition to careers as established investigators.

The Research Program encourages international and domestic applications in basic, patient-oriented, and public health topics. In the area of public health, the Research Program is particularly interested in funding projects that will inform health policy decisions. These include projects that explore the quality and safety of a specific treatment and compare the effectiveness of different therapies. 

The ATS Research Program will award up to five unrestricted research grants for $40,000 for one year for salaries, supplies, or a combination of these two. Indirect costs will not be paid to the sponsoring institution. The Research Program will award one grant to the top scores in each of the three society pillars: pulmonary, critical care, and sleep.* The remaining grants will be awarded to the top scores regardless of the category of submission. 

Award-specific eligibility:
• Early-stage investigators (as defined here)
• Must meet eligibility requirements for all grants found here


*While it is intended that there be one award in each pillar (pulmonary, critical care, and sleep medicine), the ATS Scientific Grant Review Committee (SGRC) reserves the right to alter this distribution dependent upon the significant scientific merit of applications.

Review Process

Please note that after you submit your application it will be reviewed by Research Program staff. If there are any problems or if these guidelines have not been followed, your proposal will be un-submitted. Please make sure that you check your email after you submit your application so that any outstanding issues may be addressed as quickly as possible.

The ATS Scientific Grant Review Committee (SGRC)* will review the applications at the end of February/beginning of March 2022. The membership of the SGRC is listed on the ATS Website and additional ad hoc reviewers will be invited to participate as needed. Funding decisions will be made on the basis of scientific merit, novelty, and responsiveness to the purpose of the specific grant program.

*previously known as the Scientific Advisory Committee (SAC)


ATS Policy on Additional Grant Funding

Simultaneous submission of grants with scientific overlap is allowed, but if multiple applications are funded, then the applicant must notify the Research Program within one month of formal notification of award. A subcommittee of the SGRC will assess the degree of overlap. In the case of significant scientific overlap, the applicant will have to choose between the ATS research grant and the other grant. Budgetary overlap is not allowed.


If your question is not answered in the FAQ, contact the ATS Research Program at researchprogram@thoracic.org.

The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.

Twitter Facebook LinkedIn Instagram YouTube Social Media Page

AMERICAN THORACIC SOCIETY
25 Broadway
New York, NY 10004
United States of America

Phone: +1 (212) 315-8600
Fax: +1 (212) 315-6498
Email: atsinfo@thoracic.org

© 1998 - American Thoracic Society, all rights reserved.